Table 4.

Clinical and Laboratory Characteristics of 28 Patients with Hereditary Thrombophilia and Idiopathic Pulmonary Embolism

AT, antithrombin; PC, protein C; PS, protein S; PLG, plasminogen; DVT, deep vein thrombosis, VTE, venous thromboembolism.

^*Adverse outcomes included death, cardiopulmonary resuscitation, thrombolysis, surgical embolectomy and use of percutaneous cardiopulmonary support, inotropes, and mechanical ventilation.

^†Mean±SD for each protein C, protein S, antithrombin, and plasminogen.

^‡Normal range of each anticoagulant from our institutional criteria.